BIOS Fund II, LP 13D and 13G filings for IN8bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-29 4:00 pm Purchase | 2025-12-22 | 13D | IN8BIO INC INAB | BIOS Fund II, LP | 391,357 4.000% | 87,355 (+28.74%) | Filing |
| 2025-05-08 5:53 pm Sale | 2025-05-02 | 13D | IN8BIO INC INAB | BIOS Fund II, LP | 304,002 9.990% | -43,204 (-12.44%) | Filing |
| 2024-10-11 6:01 pm Unchanged | 2024-10-04 | 13D | IN8BIO INC INAB | BIOS Fund II, LP | 347,206 23.100% | 0 (Unchanged) | Filing |
| 2023-12-15 06:08 am Purchase | 2023-12-13 | 13D | IN8BIO INC INAB | BIOS Fund II, LP | 347,206 23.100% | 125,943 (+56.92%) | Filing |
| 2021-08-13 4:16 pm Purchase | 2021-08-03 | 13D | IN8BIO INC INAB | BIOS Fund II, LP | 221,263 35.400% | 221,263 (New Position) | Filing |